Literature DB >> 1467067

Hemodialysis needles can be pain free: use of a topical anaesthetic cream.

S McPhail.   

Abstract

Many patients on hemodialysis experience pain and anxiety related to fistula punctures. The purpose of this study was to investigate the analgesic effect of an anaesthetic (lidocaine/prilocaine) cream when used to alleviate pain from the insertion of hemodialysis needles. The study took place over a 12-month time frame with a total of seven patients participating in the study. Before the patient entered the study, an assessment was made by the nursing staff as to the degree of pain and/or anxiety experienced by the patient in relation to needling. Patients were instructed regarding application of the cream. We have found this cream to be an effective topical anaesthetic in preventing pain and alleviating anxiety associated with needling. All patients involved in the study have expressed the desire to continue use of the cream. Use of this topical anaesthetic could also have great ramifications for paediatric dialysis, venipunctures and other procedures requiring topical anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467067

Source DB:  PubMed          Journal:  J CANNT        ISSN: 1483-698X


  3 in total

1.  Vapocoolant spray vs lidocaine/prilocaine cream for reducing the pain of venipuncture in hemodialysis patients: a randomized, placebo-controlled, crossover study.

Authors:  Gülperi Çelik; Orhan Özbek; Mümtaz Yılmaz; Ipek Duman; Seda Özbek; Seza Apiliogullari
Journal:  Int J Med Sci       Date:  2011-10-12       Impact factor: 3.738

2.  Evaluation of the pain scale during arteriovenous fistula puncture with and without lidocaine gel 2% in patients undergoing haemodialysis in Kosovo.

Authors:  Rudhani Ibrahim; Morina Naim; Rashiti Premtim
Journal:  Ann Med Surg (Lond)       Date:  2022-06-11

Review 3.  Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review.

Authors:  Tonci Brkovic; Eliana Burilovic; Livia Puljak
Journal:  Patient Prefer Adherence       Date:  2016-06-23       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.